2024 - Proteomics International

2024

19/09/2024

Investor Presentation – Pitt Street Research Life Sciences Conference

29/08/2024

Blood test for kidney decline in Type 1 diabetes – Medical Forum

23/08/2024

Proteomics testing pinpoints future kidney disease risks – The Age

21/08/2024

The Silent Killer: Prevention is the next cure – Phase III Podcast

20/08/2024

How Digital Health Infrastructure and Advanced Medical Devices Will Increase the Opportunity for Personalised Care – Medhealth Insight

08/07/2024

Shares In Value Interview with ASX: PIQ Managing Director

24/06/2024

Proteomics International Inks Deal With Eurobio Scientific for French Distribution of Kidney Test – 360Dx

24/06/2024

Proteomics seals kidney disease test supply deal in France – The West Australian

17/06/2024

Proteomics engages Growth Medics to expand PromarkerD test reach in EU – Medical Device Network

17/06/2024

Proteomics boosts European presence with diabetes device – The West Australian

24/05/2024

Dr Borehams’s Crucible: Proteomics International Labs – Biotech Daily

16/05/2024

Breakthrough in fight against chemically resistant dieback – Curtin University

16/05/2024

Proteomics tech emerges as early dieback diagnosis key

28/03/2024

Investor Presentation

25/03/2024

Proteomics International Inks Deal With Oxford for Endometriosis Samples – 360Dx

25/03/2024

Proteomics teams with Oxford university for endometriosis study – The West Australian

11/03/2024

The future of Endometriosis care – Phoenix Sound By Kel Myers

06/03/2024

Proteomics gets green light to continue diagnostic mission – The West Australian

29/02/2024

Proteomics stress test stamped with European patent – The West Australian

06/02/2024

Investor presentation – Euroz Hartleys Healthcare Forum

01/02/2024

Proteomics takes forward step with blood test diagnosis – The West Australian

25/01/2024

Investor Presentation

14/01/2024

Screening for Oesophageal cancer, PromarkerEso – Healthy Living, 2GB